My guess is that we will be in Russia first because of Bhlokin, then China and Japan. We have close ties in both of these countries, and there have been studies on Recaf performed by scientists there. I like that he said we get upfront licensing payments and minimum sales quotas.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.